Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Marco Marietta; Armando Tripodi

doi:10.2450/2020.0116-20

Letter to the Editor

Blood Transfusion - 3 2020 (May-June)

Rebuttal to letter "Is thromboprophylaxis with high-dose enoxaparin really necessary for COVID-19 patients? A new “prudent” randomised clinical trial"

Marco Marietta , Armando Tripodi

Doi: 10.2450/2020.0116-20

Publication Date: 2020-05-07

Abstract

Preview
Dear Sir,
We appreciate the interest of Cattaneo and Morici in the SISET position paper on COVID-19 and haemostasis1,2.
In their comments1, they underline several interesting points relevant to the management of venous thrombosis prophylaxis in COVID-19 patients. [ … ]

References

PDF

Details
Statistics

Authors

Marco Marietta Department of Oncology and Haematology, University Hospital, Modena, Italy

Armando Tripodi "IRCCS Ca’ Granda Maggiore” Hospital Foundation, “Angelo Bianchi Bonomi” Haemophilia and Thrombosis Center and “Fondazione Luigi Villa”, Milan, Italy

Abstract viewed - 451 times
PDF downloaded - 45 times

PLASTIC RECONSTRUCTIVE AND REGENERATIVE SURGERY

Abstract

References

Downloads

Authors